Emma C Hulshof

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Genome Wide Analysis

Top Venues

European journal of human genetics : EJHG

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Sofía Lj Peeters, Maarten J Deenen, Anna Mj Thijs, Emma C Hulshof, Ron H J Mathijssen, André B P van Kuilenburg, Henk-Jan Guchelaar, Jesse Joachim Swen
UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safety. Pharmacogenomics (2023)
Emma C Hulshof, Maarten J Deenen, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Arne Risselada, Gerard A P J M Rongen, Ron H N van Schaik, Daniel J Touw, Jan van der Weide, Roos van Westrhenen, Vera H M Deneer, Henk-Jan Guchelaar, Jesse Joachim Swen
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. European journal of human genetics : EJHG (2023)
Emma C Hulshof, Maarten J Deenen, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Arne Risselada, Gerard A P J M Rongen, Ron H N van Schaik, Daniel J Touw, Jan van der Weide, Roos van Westrhenen, Vera H M Deneer, Henk-Jan Guchelaar, Jesse Joachim Swen
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. European journal of human genetics : EJHG (2022)